UNSPSC 51413501: Gapicomine

This classification denotes a vasodilating agent with the molecular formula C12H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WWW0P95393, chemically known as 4,4-(iminodimethylene)dipyridine but generally known as gapicomine, which bears US NIH Compound Identifier 68955. European Medicines Agency schedules Gapicomine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07884MIG.

UNSPSC 51413501 Gapicomine, a Commodity code, encompasses emergency pharmaceutical supply and direct-to-manufacturer prescription fulfillment programs acquired by state health agencies, municipal fire departments, and regional cooperative purchasing consortia. State and local governments buy medications under this code through sealed competitive bidding for emergency life support drugs, cooperative purchasing agreements for multi-state pharmaceutical distribution networks, and exploratory market solicitations designed to establish direct manufacturer relationships outside traditional pharmacy benefit manager channels. Issuing bodies include city fire rescue services (Tampa), state health departments (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple states including Minnesota and Oregon). The code reflects procurement activity spanning emergency response pharmaceuticals, generic multi-source products distributed through authorized wholesalers, and value-based prescription programs targeting cost management and fulfillment efficiency.

Recent activity concentrates in Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 on April 24, 2026, for Advanced Life Support Medications (response deadline April 8, 2026) with an estimated contract value of $40,000.00, requiring sealed bids for emergency drugs including Labetalol HCI, Epinephrine, Adenosine, and Diltiazem for Tampa Fire Rescue, with a Small Local Business Enterprise sheltered market designation and a 5 percent SLBE bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program targeting direct contracting between state pharmacy benefit programs and manufacturers outside traditional PBM and wholesaler arrangements. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 (response deadline March 26, 2026) for generic multi-source pharmaceuticals and OTC products, requiring vendor compliance with cGMP, DSCSA certification, and maintenance of relationships with authorized wholesalers AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson, with award anticipated July 1, 2026, for a two-year term.